Literature DB >> 19641121

Interoceptive effects of alcohol require mGlu5 receptor activity in the nucleus accumbens.

Joyce Besheer1, Julie J M Grondin, Michael C Salling, Marina Spanos, Rebekah A Stevenson, Clyde W Hodge.   

Abstract

The interoceptive effects of alcohol are major determinants of addiction liability. Metabotropic glutamate (mGlu) receptors are widely expressed in striatal circuits known to modulate drug-seeking. Given that the interoceptive effects of drugs can be important determinants of abuse liability, we hypothesized that striatal mGlu receptors modulate the interoceptive effects of alcohol. Using drug discrimination learning, rats were trained to discriminate alcohol (1 g/kg, i.g.) versus water. We found that systemic antagonism of metabotropic glutamate subtype 5 (mGlu5) receptors [10 mg/kg 2-methyl-6-(phenylethynyl)pyridine (MPEP) and 3 mg/kg 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine], but not mGlu1 receptors ([0.3-3 mg/kg JNJ16259685) (3,4-dihydro-2H-pyrano[2,3]beta-quinolin-7-yl)(cis-4-methoxycyclohexyl) methanone)], inhibited the discriminative stimulus effects of alcohol. Furthermore, mGlu5 receptor antagonism (10 mg/kg MPEP) significantly inhibited neuronal activity in the nucleus accumbens core as levels of the transcription factor c-Fos were significantly reduced. Accordingly, targeted inhibition of mGlu5 receptors (20 microg of MPEP) in the nucleus accumbens core blunted the discriminative stimulus effects of alcohol (1 g/kg). Anatomical specificity was confirmed by the lack of effect of inhibition of mGlu5 receptors (10-30 microg of MPEP) in the dorsomedial caudate-putamen and the similar cytological expression patterns and relative density of mGlu5 receptors between the brain regions. Functional involvement of intra-accumbens mGlu5 receptors was confirmed as activation of mGlu5 receptors [10 microg of (RS)-2-amino-2-(2-chloro-5-hydroxyphenyl)acetic acid sodium salt] enhanced the discriminative stimulus effects of a low alcohol dose (0.5 g/kg), and mGlu5 receptor inhibition (20 microg of MPEP) prevented the agonist-induced enhancement. These results show that mGlu5 receptor activity in the nucleus accumbens is required for the expression of the interoceptive effects of alcohol.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19641121      PMCID: PMC2845172          DOI: 10.1523/JNEUROSCI.2366-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

1.  Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG.

Authors:  Pia Bäckström; Petri Hyytiä
Journal:  Eur J Pharmacol       Date:  2005-12-01       Impact factor: 4.432

Review 2.  The integrative function of the basal ganglia in instrumental conditioning.

Authors:  Bernard W Balleine; Mimi Liljeholm; Sean B Ostlund
Journal:  Behav Brain Res       Date:  2008-11-05       Impact factor: 3.332

3.  The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice.

Authors:  Clyde W Hodge; Michael F Miles; Amanda C Sharko; Rebekah A Stevenson; Jennie R Hillmann; Veronique Lepoutre; Joyce Besheer; Jason P Schroeder
Journal:  Psychopharmacology (Berl)       Date:  2005-11-15       Impact factor: 4.530

4.  Pharmacological analysis of the mixed discriminative stimulus effects of ethanol.

Authors:  K A Grant; G Colombo
Journal:  Alcohol Alcohol Suppl       Date:  1993

5.  Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors.

Authors:  Zaida Díaz-Cabiale; Meritxell Vivó; Alberto Del Arco; William T O'Connor; Michael K Harte; Christa E Müller; Emili Martínez; Patrizia Popoli; Kjell Fuxe; Sergi Ferré
Journal:  Neurosci Lett       Date:  2002-05-17       Impact factor: 3.046

6.  mGluR1 in cerebellar Purkinje cells essential for long-term depression, synapse elimination, and motor coordination.

Authors:  T Ichise; M Kano; K Hashimoto; D Yanagihara; K Nakao; R Shigemoto; M Katsuki; A Aiba
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

7.  Roles of specific metabotropic glutamate receptor subtypes in regulation of hippocampal CA1 pyramidal cell excitability.

Authors:  R W Gereau; P J Conn
Journal:  J Neurophysiol       Date:  1995-07       Impact factor: 2.714

Review 8.  Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.

Authors:  Markus Heilig; Mark Egli
Journal:  Pharmacol Ther       Date:  2006-03-20       Impact factor: 12.310

9.  Cue-induced reinstatement of alcohol-seeking behavior is associated with increased ERK1/2 phosphorylation in specific limbic brain regions: blockade by the mGluR5 antagonist MPEP.

Authors:  Jason P Schroeder; Marina Spanos; Jennie R Stevenson; Joyce Besheer; Michael Salling; Clyde W Hodge
Journal:  Neuropharmacology       Date:  2008-07-04       Impact factor: 5.250

10.  Pharmacological and anatomical evidence for an interaction between mGluR5- and GABA(A) alpha1-containing receptors in the discriminative stimulus effects of ethanol.

Authors:  Joyce Besheer; Clyde W Hodge
Journal:  Neuropsychopharmacology       Date:  2005-04       Impact factor: 7.853

View more
  36 in total

1.  mGlu receptors and drug addiction.

Authors:  Richard M Cleva; M Foster Olive
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-01-20

2.  Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade.

Authors:  Mark R Stefani; Bita Moghaddam
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

3.  Carisoprodol pharmacokinetics and distribution in the nucleus accumbens correlates with behavioral effects in rats independent from its metabolism to meprobamate.

Authors:  Theresa M Carbonaro; Vien Nguyen; Michael J Forster; Michael B Gatch; Laszlo Prokai
Journal:  Neuropharmacology       Date:  2020-05-29       Impact factor: 5.250

4.  The effects of repeated corticosterone exposure on the interoceptive effects of alcohol in rats.

Authors:  Joyce Besheer; Kristen R Fisher; Julie J M Grondin; Reginald Cannady; Clyde W Hodge
Journal:  Psychopharmacology (Berl)       Date:  2011-10-21       Impact factor: 4.530

5.  Metabotropic Glutamate Receptors in Alcohol Use Disorder: Physiology, Plasticity, and Promising Pharmacotherapies.

Authors:  Max E Joffe; Samuel W Centanni; Anel A Jaramillo; Danny G Winder; P Jeffrey Conn
Journal:  ACS Chem Neurosci       Date:  2018-06-08       Impact factor: 4.418

6.  Functional role for cortical-striatal circuitry in modulating alcohol self-administration.

Authors:  Anel A Jaramillo; Patrick A Randall; Spencer Stewart; Brayden Fortino; Kalynn Van Voorhies; Joyce Besheer
Journal:  Neuropharmacology       Date:  2017-11-26       Impact factor: 5.250

7.  Activation of group II metabotropic glutamate receptors inhibits the discriminative stimulus effects of alcohol via selective activity within the amygdala.

Authors:  Reginald Cannady; Julie J M Grondin; Kristen R Fisher; Clyde W Hodge; Joyce Besheer
Journal:  Neuropsychopharmacology       Date:  2011-07-06       Impact factor: 7.853

Review 8.  Implication of the purinergic system in alcohol use disorders.

Authors:  Liana Asatryan; Hyung W Nam; Moonnoh R Lee; Mahesh M Thakkar; M Saeed Dar; Daryl L Davies; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2011-01-11       Impact factor: 3.455

9.  Role of mPFC and nucleus accumbens circuitry in modulation of a nicotine plus alcohol compound drug state.

Authors:  Patrick A Randall; Zoe A McElligott; Joyce Besheer
Journal:  Addict Biol       Date:  2019-06-07       Impact factor: 4.280

Review 10.  Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder.

Authors:  Sunil Goodwani; Hannah Saternos; Fawaz Alasmari; Youssef Sari
Journal:  Neurosci Biobehav Rev       Date:  2017-02-24       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.